share_log

Short Interest in Pharming Group (OTCMKTS:PHGUF) Drops By 46.4%

Short Interest in Pharming Group (OTCMKTS:PHGUF) Drops By 46.4%

空頭股數在醫藥集團(OTCMKTS：PHGUF)下跌46.4%
kopsource ·  2022/07/18 03:21

Pharming Group (OTCMKTS:PHGUF – Get Rating) was the target of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 1,279,100 shares, a drop of 46.4% from the June 15th total of 2,387,900 shares. Based on an average daily volume of 1,000 shares, the days-to-cover ratio is currently 1,279.1 days.

6月份，輝瑞集團(Pharing Group)是空頭股數大跌的目標。截至6月30日，空頭股數共有127.91萬股，較6月15日的238.79萬股減少46.4%。以日均成交量1,000股計算，目前天數與回補比率為1,279.1天。

Pharming Group Stock Performance

輝瑞集團股票表現

Pharming Group stock remained flat at $0.79 during mid-day trading on Friday. The company has a fifty day simple moving average of $0.80 and a two-hundred day simple moving average of $0.85. Pharming Group has a twelve month low of $0.74 and a twelve month high of $1.18. The company has a current ratio of 5.33, a quick ratio of 4.75 and a debt-to-equity ratio of 0.82.

在週五午盤交易中，輝瑞集團股價持平於0.79美元。該公司的50日簡單移動均線切入位在0.80美元，200日簡單移動均線切入位在0.85美元。輝瑞集團的股價為0.74美元的12個月低點和1.18美元的12個月高位。該公司的流動比率為5.33，速動比率為4.75，債務權益比率為0.82。

Get
到達
Pharming Group
Pharing Group
alerts:
警報：

Pharming Group Company Profile

柏寧集團公司簡介

(Get Rating)

(獲取評級)

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema.
生物製藥公司Pharing Group N.V.開發蛋白質替代療法和精準藥物並將其商業化，用於治療美國、歐洲和國際上未得到滿足的罕見疾病和醫療需求。該公司的主導產品是Ruconest，一種用於治療急性遺傳性血管性水腫的重組人C1酯酶抑制劑。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Pharming Group (PHGUF)
  • MarketBeat: Week in Review 7/11 – 7/15
  • Should You Have These Two Banks In Your Portfolio?
  • Is Coupang's Stock On The Verge Of A Turnaround?
  • Why Shopify Stock Split...And is as Shoppable as Ever
  • Verint Systems Stock is a Customer Engagement Play
  • 免費獲取StockNews.com關於Pharming Group的研究報告(PHGUF)
  • MarketBeat：回顧一週7/11-7/15
  • 你的投資組合中應該有這兩家銀行嗎？
  • Coupang的股票即將翻身嗎？
  • 為什麼Shopify股票拆分...並一如既往地適合購物
  • Verint Systems Stock是一場客户互動活動

Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.

接受Pharming Group Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pharming Group和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論